| Issue | Title | |
| Vol 10, No 2 (2009) | Theory and practice of the Health Technology Assessment in countries with a predominant public health service | Details PDF |
| Mario Eandi | ||
| Vol 7, No 4 (2006) | Tigecycline: a review of the literature | Abstract PDF |
| Mario Venditti, Maria Elena Pompeo, Flavia Fabi | ||
| Vol 12, No 2 (2011) | Tiotropium bromide in the routine care of GOLD stage II COPD patients: a pharmaeconomic evaluation | Abstract HTML PDF |
| Orietta Zaniolo, Michela Carsi, Sergio Iannazzo | ||
| Vol 11, No 1 (2010) | Tiotropium in COPD: clinical outcomes and economic evidence | Abstract PDF |
| Orietta Zaniolo, Viola Sacchi, Roberto W. Dal Negro | ||
| Vol 13, No 2S (2012) | Toscana | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Toscana | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 2, No 1 (2001) | Traiettorie tecniche e Metodologia QWERTY: come si applicano alle innovazioni farmaceutiche | Abstract PDF |
| Marina Altagracia, Mario Cimoli, Jaime Kravzov, Rafael Castillo, Ofelia Espejo, Albert I. Wertheimer | ||
| Vol 5, No 3 (2004) | Tramadolo: profilo farmacologico, terapeutico e farmacoeconomico | Abstract PDF |
| Loredana Serpe, Lorenzo Pradelli, Mario Eandi | ||
| Vol 4, No 1 (2003) | Trattamento con etanercept dei soggetti con artrite reumatoide in Italia: considerazioni economiche | Abstract PDF |
| Lorenzo G. Mantovani | ||
| Vol 14, No 1 (2013) | Treatment cost of metastatic colon cancer in Turkey | Abstract HTML PDF |
| Guvenc Kockaya, Mine Polat, Albert Wertheimer, Ahmet Ozet, Simten Malhan, İsmail Mert Vural, Akif Akbulat, Guven Artıran, Hakkı Gursoz, Saim Kerman | ||
| Vol 20, No 1 (2019) | Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs | Abstract HTML PDF |
| Francovito Piantedosi, Raffaela Cerisoli, Ciro Battiloro, Francesca Andreozzi, Fabiana Vitiello, Marina Gilli, Valeria De Marino, Antonietta Letizia, Antonella Bianco, Ivana Caprice, Adele Savoia, Adriano Cristinziano, Giorgia Smeraglio, Danilo Rocco | ||
| Vol 10, No 4 (2009) | Trends in prescribing and persistence with antihypertensive therapy: results of the study PAPEETE (Population-based Analysis of Persistence and Economics of treatment with telmisartan) study | Abstract PDF |
| Francesco Vittorio Costa | ||
| Vol 13, No 2S (2012) | Trento | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Trento | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 13, No 2S (2012) | Umbria | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Umbria | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 1, No 2 (2000) | Una checklist per la gestione dei costi nel trattamento dell’HIV | Abstract PDF |
| Vasilisa Sazonov, Uros Urleb, Albert L. Wertheimer | ||
| Vol 5, No 4 (2004) | Una valutazione economica di citrato di fentanile ad assorbimento orale (Actiq®) per la terapia del dolore in pazienti affetti da cancro | Abstract PDF |
| C. Lucioni, S. Mazzi | ||
| Vol 3, No 4 (2002) | Unita di consumo dei farmaci e valutazioni farmacoeconomiche: uso e misuso di DDD e PDD | Abstract PDF |
| Mario Eandi | ||
| Vol 9, No 4 (2008) | Usefulness and limitation of DDD and PDD analyses. 12 months of solid oral antipsychotics prescribing data for the NHS-reimbursed treatment of schizophrenia in Italy | Abstract PDF |
| Lorenzo Pradelli | ||
| Vol 16, No 3 (2015) | Using Patient-Reported Outcomes to Include the Patient in Research, Care, and Quality | Details HTML PDF |
| Priya Gaur, Nikita Jeswani, Nelly Ganesan | ||
| Vol 3, No 3 (2002) | Utilità e costo/efficacia del dinoprostone in ostetricia | Abstract PDF |
| Mario Eandi, Lorenzo Pradelli, Chiara Benedetto | ||
| Vol 18, No 1 (2017) | Utilization patterns of complementary and alternative medicine in Australia, Canada and the United States: popularity of dietary supplements, mind-body and manipulative therapies | Details HTML PDF |
| Marina Luketina Sunjka, Ana Pejcic, Mihajlo Jakovljevic | ||
| Vol 13, No 2S (2012) | Valle d’Aosta | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Valle d’Aosta | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 12, No 1S (2011) | Valsartan: come versatilità e tollerabilità possono contribuireal contenimento della spesa sanitaria | Abstract PDF |
| Francesco Vittorio Costa | ||
| Vol 13, No 4 (2012) | Value of drug or valuable drug: a point of view issue | Details HTML PDF |
| Francesca Patarnello | ||
| Vol 6, No 4 (2005) | Valutazione clinica e metabolica dell’impiego dell’insulina Lispro in pazienti con diabete mellito scompensato | Abstract PDF |
| Antonio Uneddu, Tito Antonio Paolini | ||
| Vol 2, No 4 (2001) | Valutazione dei costi di trattamento dei disturbi psicotici con olanzapina, risperidone e neurolettici tipici di un DSM italiano | Abstract PDF |
| I. Rossi, L. Guidi | ||
| Vol 12, No 2S (2011) | Valutazione dei processi assistenziali e del carico economico dei soggetti con ospedalizzazione incidente di infarto acuto del miocardio mediante il Data Warehouse DENALI | Abstract PDF |
| Lorenzo G. Mantovani, Carla Fornari, Fabiana Madotto, Michele A. Riva, Luca Merlino, Virginio Chiodini, Giancarlo Cesana | ||
| Vol 4, No 1 (2003) | Valutazione del turn over dei farmaci antiretrovirali in particolare da IP a NNRTI | Abstract PDF |
| Sergio Sabbatani, Raffaella Cesari, Emanuela Pipitone, Francesco Chiodo | ||
| Vol 2, No 2 (2001) | Valutazione dell’impatto delle politiche del prezzo di riferimento sul mercato degli H2-antagonisti nella British Columbia, Canada | Abstract PDF |
| Lutchmie Narine, Mahil Senathirajah, Tina Smith, Albert I. Wertheimer | ||
| Vol 14, No 1 (2013) | Valutazione di efficienza nella somministrazione dell’ormone della crescita (GH) | Abstract HTML PDF |
| Federico Spandonaro, Letizia Mancusi | ||
| Vol 6, No 4 (2005) | Valutazione economica dei costi associati al trattamento di pazienti in ossigenoterapia a lungo termine, con o senza monitoraggio telemetrico domiciliare | Abstract PDF |
| Roberto Ravasio, Roberto W. Dal Negro, Carlo Lucioni | ||
| Vol 8, No 2S (2007) | Valutazione economica delle terapie farmacologiche | Details PDF |
| Lorenzo G. Mantovani, Simona Cammarota | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio AVERT | Abstract PDF |
| Simona De Portu, Simona Cammarota, Enrica Menditto, Lorenzo G. Mantovani | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio CARDS | Abstract PDF |
| Simona de Portu, Enrica Menditto, Lorenzo G. Mantovani | ||
| Vol 12, No 2S (2011) | Valutazione economica dello studio CARDS: un aggiornamento | Abstract PDF |
| Simona de Portu, Sabato Montella, Paolo Cortesi, Enrica Menditto, Lorenzo G. Mantovani | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio IDEAL | Abstract PDF |
| Enrica Menditto, Anna Citarella | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio MIRACL | Abstract PDF |
| Simona De Portu, Sabato Montella, Simona Cammarota, Lorenzo G. Mantovani | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio PROVE-IT | Abstract PDF |
| Lorenzo G. Mantovani, Sabato Montella, Anna Citarella, Simona De Portu | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio TNT | Abstract PDF |
| Lorenzo G. Mantovani, Sabato Montella, Anna Citarella, Simona De Portu | ||
| Vol 4, No 2 (2003) | Valutazione economica di Infliximab (Remicade®) vs Etanercept (Enbrel®) nel trattamento dell’artrite reumatoide | Abstract PDF |
| G. L. Colombo, A. Muzio, A. Longhi | ||
| Vol 6, No 4 (2005) | Valutazione farmacoeconomica della prevenzione con picotamide vs acido acetilsalicilico dei pazienti diabetici con vasculopatia periferica | Abstract PDF |
| Sergio Iannazzo, Lorenzo Pradelli, Mario Eandi | ||
| Vol 4, No 1 (2003) | Valutazione farmacoeconomica dell’uso di tramadolo vs ketorolac nella gestione del dolore postoperatorio | Abstract PDF |
| Lorenzo G. Mantovani | ||
| Vol 2, No 3 (2001) | Valutazione farmacoeconomica di una casistica di pazienti con riacutizzazione di bronchite cronica | Abstract PDF |
| M. Liconti, M. Polimeni, C. Filloramo, F. Reale | ||
| Vol 12, No 2S (2011) | Valutazioni economiche di atorvastatina in prevenzione secondaria: un aggiornamento | Abstract PDF |
| Simona de Portu, Sabato Montella, Paolo Cortesi, Enrica Menditto, Simona Cammarota, Anna Citarella, Lorenzo G. Mantovani | ||
| Vol 18, No 1 (2017) | Varenicline treatment for smoking cessation in high risk patients: a budget impact analysis | Abstract HTML PDF |
| Federico Spandonaro, Letizia Mancusi, Barbara Polistena | ||
| Vol 13, No 2S (2012) | Veneto | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Veneto | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 14, No 3 (2013) | Venous thrombo-embolism (VTE) prevention of patients undergoing total hip and knee replacement: budget impact analysis of apixaban in Italy | Abstract HTML PDF |
| Lorenzo Giovanni Mantovani, Giovanni Di Minno, Gianluca Furneri | ||
| Vol 15, No 4 (2014) | Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy | Abstract HTML PDF |
| Daniela Paola Roggeri, Alessandro Roggeri, Vittorio Pengo | ||
| Vol 13, No 2 (2012) | What are key determinants of hospital admissions, readmission rate and day case rate within the South African medical schemes population? | Abstract HTML PDF |
| Nondumiso Gugu Khumalo, Michael Willie, Evelyn Thsehla | ||
| Vol 8, No 2 (2007) | Which future for pharmacoeconomics in Italy? | Details PDF |
| Mario Eandi | ||
| Vol 17, No 2S (2016) | [Budget impact analysis for peginterferon beta-1a in relapsing remitting multiple sclerosis in Italy] | Abstract HTML PDF |
| Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Giulia Vestri, Luigi Giuliani, Diego Centonze, Pier Luigi Canonico | ||
| Vol 17, No 1 (2016) | [Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy] | Abstract HTML PDF |
| Gianluca Furneri, Chiara Marchesi, Laura Santoni | ||
| Vol 17, No 1 (2016) | [Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy] | Abstract HTML PDF |
| Sergio Iannazzo, Edoardo Mannucci, Lorenzo Mantovani | ||
| Vol 17, No 2 (2016) | [Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy] | Abstract HTML PDF |
| Andrea Belisari, Sergio Iannazzo, Giuseppe Di Pasquale, Claudio Fresco, Lorenzo Giovanni Mantovani, Maria Pia Ruggeri, Danilo Toni, Raffaele Landolfi | ||
| Vol 23, No 1 (2022) | [Budget Impact Analysis of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly in Italy] | Abstract HTML PDF |
| Vincenzo Baldo, Marco Bellone | ||
| Vol 24, No 1 (2023) | [Burden of Short Bowel Syndrome in Italy: Direct and Indirect Costs and Quality of Life] | Abstract HTML PDF |
| Francesco Saverio Mennini, Chiara Bini, Martina Paoletti, Andrea Marcellusi, Paolo Sciattella, Raffaella Viti, Lucrezia Amoroso, Laura Fioravanti, Gennaro Di Martino, Angela Ragonese, Riccardo Caccialanza, Lorenzo Norsa, Antonella Diamanti, Loris Pironi | ||
| Vol 17, No 3S (2016) | [Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market] | Abstract HTML PDF |
| Lorenzo Pradelli, Paolo Ascierto | ||
| Vol 25, No 1 (2024) | [Cost per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis] | Abstract HTML PDF |
| Massimiliano Povero, Luca Castello, Lorenzo Pradelli, Elena Visentin | ||
| Vol 17, No 2 (2016) | [Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy] | Abstract HTML PDF |
| Gianluca Furneri, Laura Santoni, Chiara Marchesi, Sergio Iannazzo, Paolo Angelo Cortesi, Achille Patrizio Caputi, Lorenzo Giovanni Mantovani | ||
| Vol 24, No 1 (2023) | [Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy] | Abstract HTML PDF |
| Andrea Marcellusi, Chiara Bini, Simone Corinti, Laura Fioravanti, Laura Dalla Vedova, Stacey L. Amorosi, Tam De Lacey, Emtiyaz Chowdhury, Francesco Saverio Mennini | ||
| Vol 16, No 4 (2015) | [Cost-effectiveness analysis of ocriplasmin in the treatment of vitreomacular traction in Italy] | Abstract HTML PDF |
| Lucia Sara D'Angiolella, Riccardo Miglietta, Francesco Bandello, Stanislao Rizzo, Lorenzo Giovanni Mantovani | ||
| Vol 17, No 2S (2016) | [Cost-effectiveness analysis of peginterferon beta-1a in Italian relapsing remitting multiple sclerosis management] | Abstract HTML PDF |
| Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Giulia Vestri, Luigi Giuliani, Pier Luigi Canonico, Diego Centonze | ||
| Vol 17, No 2 (2016) | [Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease] | Abstract HTML PDF |
| Giancarlo Castaman | ||
| Vol 23, No 1 (2022) | [Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy] | Abstract HTML PDF |
| Elena Galli, Maria Paola Pedone, Miryana Dobreva, Rossella Bitonti, Roberta Di Turi | ||
| Vol 25, No 1 (2024) | [Enhanced Influenza Vaccines Under Review by the ECDC and the Latest Scientific Literature] | Details HTML PDF |
| Pier Luigi Lopalco | ||
| Vol 25, No 1 (2024) | [Implantation of Reveal LINQ in Different Italian Scenarios: How to Further Improve?] | Abstract HTML PDF |
| Gaetano Senatore, Emilio Di Lorenzo, Orietta Zaniolo, Giovanni Liuzzi | ||
| Vol 18, No 1 (2017) | [In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”] | Details HTML PDF |
| Matteo Ferrario, Giovanni Giuliani | ||
| Vol 17, No 2 (2016) | [Kovaltry® for the replacement therapy in patients with Hemophilia A] | Abstract HTML PDF |
| Daniela Paola Roggeri, Alessio Colombo, Alessandro Roggeri | ||
| Vol 24, No 1S (2023) | [Measurement-Based Procurement Approach for Biosimilars in Italy: A Position Paper] | Abstract HTML PDF |
| Arturo Cavaliere, Francesco Saverio Mennini, Marcello Pani, Paolo Gennaro Torrico, Salvatore Torrisi | ||
| Vol 18, No 1S (2017) | [Nintedanib for the treatment of idiopathic pulmonary fibrosis in Italy] | Abstract HTML PDF |
| Andrea Belisari, Daria Bettoni, Paolo Angelo Cortesi, Lucia Sara D'Angiolella, Lorenzo Giovanni Mantovani, Gerardo Miceli Sopo, Marino Nonis | ||
| Vol 17, No 3 (2016) | [Organizational and financial aspects of the introduction of Botox® in the clinical diagnostic therapeutic process of chronic migraine at a Local Health Unit in Italy] | Abstract HTML PDF |
| Francesca Cioffi, Marco Oradei, Rosanna Cerbo, Vittorio Di Pietro, Giovanna Riccioni, Gianni Pardhanani, Eleonora Capannini, Michele Basile | ||
| Vol 17, No 2S (2016) | [Pegylated interferon beta-1a on the Italian market] | Abstract HTML PDF |
| Mario Eandi | ||
| Vol 17, No 2S (2016) | [Pegylation and interferons in multiple sclerosis] | Abstract HTML PDF |
| Diego Centonze, Elisa Puma, Cecilia Saleri, Giulia Vestri, Sergio Iannazzo, Laura Santoni, Luigi Giuliani, Pier Luigi Canonico | ||
| Vol 18, No 1 (2017) | [Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”] | Details HTML PDF |
| Lorenzo Pradelli, Paolo Ascierto | ||
| Vol 18, No 2S (2017) | [Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis] | Abstract HTML PDF |
| Lorenzo Giovanni Mantovani, Gianluca Furneri, Paolo Angelo Cortesi, Maria Pia Amato, Achille Patrizio Caputi, Patrizio Piacentini, Alessandra Solari, Carlo Pozzilli, Giancarlo Comi | ||
| Vol 22, No 2S (2021) | [The Multidisciplinary Management of Type 2 Diabetes: an Integrated Care Model] | Abstract HTML PDF |
| Cesare Celeste Berra, Lorenzo Pradelli | ||
| Vol 18, No 1 (2017) | [Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials] | Abstract HTML PDF |
| Lucia Sara D'Angiolella, Angelo Claudio Molinari, Paolo Angelo Cortesi, Antonio Coppola, Lorenzo Giovanni Mantovani | ||
| 401 - 481 of 481 Items | << < 1 2 3 4 5 | |
User
Font Size